STOCK TITAN
  1. Home
  2. Sec-filings
  3. SGMT
  4. [144] Sagimet Biosciences Inc. SEC Filing

Sagimet Biosciences (SGMT) insider plans 20,206-share stock sale after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SGMT insider George Kemble filed to sell common stock under a Rule 10b5-1 trading plan. The filing lists up to 20,206 shares of common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $193,371.42, to be sold for cash on or after August 11, 2026 following an exercise of stock options. It also notes a prior 10b5-1 sale of 18,844 shares of common stock on July 20, 2026 for $140,529.13.

Positive

  • None.

Negative

  • None.
Shares to be sold 20,206 shares Common stock planned for sale following exercise of stock options
Aggregate market value (planned sale) $193,371.42 Value of 20,206 SGMT common shares to be sold
Prior 10b5-1 sale shares 18,844 shares Common stock sold on July 20, 2026 under 10b5-1
Prior 10b5-1 sale value $140,529.13 Aggregate value of 18,844 shares sold on July 20, 2026
Planned sale date 08/11/2026 Date for planned sale after stock option exercise
Form 144 regulatory
"SGMT insider George Kemble filed to sell common stock under Form 144."
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Rule 10b5-1 regulatory
"It also notes a prior 10b5-1 sale of 18,844 shares of common stock."
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Exercise of Stock Options financial
"to be sold for cash on or after August 11, 2026 following an exercise of stock options."
aggregate market value financial
"with an aggregate market value of $193,371.42 to be sold for cash."
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does SGMT's latest Form 144 filing disclose?
The filing discloses that George Kemble plans to sell 20,206 shares of SGMT common stock, valued at $193,371.42, following an exercise of stock options, with sales handled through Morgan Stanley Smith Barney LLC.

How many SGMT shares are planned for sale in this Form 144?
The Form 144 reports a planned sale of 20,206 shares of SGMT common stock. These shares are associated with an exercise of stock options and are to be sold for cash through Morgan Stanley Smith Barney LLC Executive Financial Services.

What is the reported market value of SGMT shares in the Form 144?
The Form 144 lists an aggregate market value of $193,371.42 for the 20,206 shares of SGMT common stock to be sold. This value reflects the market price used for the filing’s disclosure, not necessarily the final sale proceeds.

Does the SGMT Form 144 mention prior sales by George Kemble?
Yes. It notes prior 10b5-1 sales of SGMT common stock by George Kemble on July 20, 2026, covering 18,844 shares with an aggregate value of $140,529.13 during the past three months.

What is the planned method of sale for SGMT shares in this filing?
The filing indicates the SGMT common shares will be sold for cash following an exercise of stock options. Sales are to be executed via Morgan Stanley Smith Barney LLC Executive Financial Services, with the stock listed on NASDAQ.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR